01-07-2012
Preoperative Treatment Does Not Improve the Therapeutic Results of Abdominosacral Amputation of the Rectum
Published in: World Journal of Surgery | Issue 7/2012
Login to get accessAbstract
Background
This study reviewed the impact of preoperative chemoradiotherapy/short-term radiotherapy on abdominosacral amputations of the rectum (ASAR) for the treatment of low-rectum cancers in terms of postoperative morbidity, local recurrence rates, and survival.
Methods
A total of 198 patients with stage II and III tumors located within 6 cm of the anorectal junction underwent ASAR between 1998 and 2008 and were selected for further analysis. Patients were compared according to the following groups: those who had surgery only (Group A) and those who had preoperative chemoradiotherapy/short-term radiotherapy (Group B).
Results
There were 44 and 154 patients in Groups A and B, respectively, including 135 males. The median age of the subjects was 63 years (range = 35–88). The median follow-up period was 81 months (range = 23–138). Neither the local recurrence rates (6.8% in Group A vs. 4.6% in Group B, p = 0.544) nor the 5-year relative survival rates (72.4% in Group A vs. 69.3% in Group B, p = 0.127) differed significantly between the groups.
Conclusion
Preoperative therapy in low-rectum cancer does not improve the therapeutic results of ASAR.